Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiyuancong
- Development stage
- Unknown
- Lead developer
- Guangzhou University of Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yiyuancong is a Traditional Chinese Medicine (TCM) formula, typically administered in capsule form, developed for the treatment of Mild Cognitive Impairment (MCI) and Alzheimer's disease. The formula is composed of several botanical extracts, including *Polygonum multiflorum*, *Acorus tatarinowii*, and *Alisma orientale*. It is thought to exert its therapeutic effects through a multi-target approach, including the inhibition of acetylcholinesterase (AChE) to boost cholinergic transmission, the reduction of amyloid-beta (Aβ) plaque formation, and the provision of neuroprotective antioxidant effects. Developed primarily by researchers at the Guangzhou University of Chinese Medicine, Yiyuancong has been evaluated in clinical trials in China to assess its ability to improve memory and cognitive function in patients with early-stage dementia.
- Brand names
- Yiyuancong
- Other names
- Yiyuancong CapsuleYi Yuan Cong
02
Targets
AcetylcholinesteraseAβ (Amyloid-beta peptides and aggregates)
Beyond the preview
Go deeper on Yiyuancong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yiyuancong.